Riya Gandhi

Patients with psoriatic arthritis (PsA) face elevated risks of sarcopenia and osteoporosis, according to a single-center retrospective study published in Nutrition. Evaluating 156 individuals diagnosed with PsA who underwent dual-energy X-ray absorptiometry, the research sheds light on the overlap between muscle and bone health in this population.

A blend of ancient ethnopharmacology and modern science has highlighted the potential of Pongamia pinnata, a plant renowned in traditional medicine, as a promising candidate for treating skin cancer. A recent in-silico and in-vitro study published in the Journal of Ethnopharmacology unveils its potent anti-cancer and antioxidant properties, offering a pathway to innovative therapeutic applications.

A recent study from the Lupus Midwest Network published in Rheumatology examined the prevalence and incidence of multimorbidity in patients with systemic lupus erythematosus (SLE) and its association with disease-related damage.

A recent analysis of digestive disease mortality trends in the U.S. from 2000 to 2019 uncovered troubling racial and ethnic disparities that persist despite an overall decline in death rates, reported researchers in Clinical Gastroenterology Hepatology.

Type 2 (T2) inflammation underlies a range of diseases that often coexist, including asthma, atopic dermatitis, eosinophilic esophagitis, and allergic rhinitis. Despite advancements in understanding and treating these conditions, the absence of effective interdisciplinary communication and diagnostic tools frequently delays proper care.

According to a study published in the Journal of Clinical Rheumatology, both tumor necrosis factor blockers (anti-TNF) and Janus kinase inhibitors (JAKi) reduce the prothrombotic tendency in rheumatoid arthritis (RA) patients during the first 6 months of treatment.

A new management framework for metabolic dysfunction-associated steatosis and steatohepatitis (MASLD/MASH) offers a pragmatic, risk-based strategy for clinicians dealing with the complexities of these liver diseases, which often coexist with obesity and other metabolic comorbidities.

A recent multicenter cohort study published in the Journal of the American Academy of Dermatology has identified dupilumab as a safer alternative to traditional immunosuppressants in reducing the risk of acute upper respiratory infections (URIs) for patients with atopic dermatitis (AD). This chronic inflammatory skin condition often requires systemic therapies for moderate-to-severe cases, with conventional immunosuppressants like methotrexate, cyclosporine, and azathioprine carrying risks of adverse effects, including infections.

A post hoc analysis of the ORAL surveillance study presented at the American College of Rheumatology (ACR) Convergence 2024, held November 14-19 in Washington, DC, sheds new light on cardiovascular (CV) risk management for rheumatoid arthritis (RA) patients. The study emphasizes the importance of statin use in reducing major adverse cardiovascular events (MACE) in patients with a history of atherosclerotic cardiovascular disease (ASCVD) treated with tofacitinib.

A post hoc analysis of the SELECT-PsA Phase 3 trials evaluated the impact of upadacitinib (UPA15) on enthesitis in patients with psoriatic arthritis (PsA). The study published in Rheumatology compared the effects of UPA15 against placebo in patients who had an inadequate response or intolerance to 1 or more disease-modifying antirheumatic drugs (DMARDs).